Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2119 | Let It Out (LIO)-C Wiki | 1.00 |
| drug963 | Colchicine Wiki | 0.29 |
Navigate: Correlations HPO
There is one clinical trial.
A randomised controlled trial designed to test whether an online expressive writing intervention (LIO-C) can reduce distress for English-speaking adults during the global COVID19 pandemic. Hypothesis: LIO-C will improve distress (as measured by K10) in adults at 1 week post-intervention compared to a neutral writing control during the COVID19 pandemic.
Description: 10-item self-report distress scale
Measure: Kessler Psychological Distress Scale (K10) Time: 1 week post-interventionDescription: 10-item self-report distress scale
Measure: Kessler Psychological Distress Scale (K10) Time: Immediately and 8 weeks post-interventionDescription: Self-report stress scale
Measure: Perceived Stress Scale (PSS-10) Time: Immediately, 1 week and 8 weeks post-interventionDescription: Self-report sleep scale
Measure: Pittsburgh Sleep Quality Index (PSQI) Time: Immediately, 1 week and 8 weeks post-interventionDescription: Self-report self-compassion scale
Measure: Self-compassion scale (SCS) Time: Immediately, 1 week and 8 weeks post-interventionDescription: Self-report loneliness scale
Measure: UCLA Loneliness Scale (UCLA LS) Time: Immediately, 1 week and 8 weeks post-interventionDescription: Self-report measure of MHS usage
Measure: Uptake of existing mental health services (MHS) Time: Immediately, 1 week and 8 weeks post-interventionDescription: 3-item, 7-point, Likert scale measuring how personal and meaningful participants' felt their writing was and their mood
Measure: Mood and meaning Time: Immediately after each writing sessionDescription: Via an online feedback form
Measure: Acceptability Time: Immediately post-interventionAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports